Autonomic Nervous System Drugs Practice Questions

Q: Which of the following is a contraindication to the use of Beta Blockers:

Severe asthma with bronchospasm. ***Severe asthma with bronchospasm*** - Beta-blockers, especially **non-selective ones**, can block beta-2 receptors in the lungs, leading to **bronchoconstriction** and worsening asthma symptoms. - This can precipitate a severe **asthma attack** and respiratory distress, making it an **absolute contraindication**. - Even cardioselective beta-blockers should be avoided in severe asthma. *Thyroid storm* - Beta-blockers are often used in **thyroid storm** to manage hyperadrenergic symptoms like **tachycardia** and **tremors**. - Propranolol also has the added benefit of inhibiting peripheral conversion of T4 to T3. - They are not contraindicated but rather an important part of treatment. *Glaucoma* - Topical beta-blockers (e.g., timolol) are commonly used to treat **glaucoma** by **reducing aqueous humor production**, thereby lowering intraocular pressure. - Oral beta-blockers also have this effect and are not contraindicated in glaucoma. *AV nodal reentrant tachycardia (AVNRT)* - Beta-blockers are frequently used in the management of **AVNRT** by slowing AV nodal conduction. - They are effective in both acute termination and prophylaxis of AVNRT episodes. - **Note:** Beta-blockers ARE contraindicated in **atrial fibrillation with Wolff-Parkinson-White syndrome** (pre-excited AF), as blocking the AV node can preferentially conduct through the accessory pathway, potentially causing ventricular fibrillation.

Q: All are drugs which lower IOP except:

Dexamethasone. ***Dexamethasone*** - Dexamethasone is a **corticosteroid** that is known to increase **intraocular pressure (IOP)**, particularly with prolonged use, in susceptible individuals. - This increase in IOP is a significant side effect and can lead to **steroid-induced glaucoma**. *Mannitol* - **Mannitol** is an osmotic diuretic that rapidly reduces IOP by creating an osmotic gradient, drawing water out of the eye. - It is often used in acute settings for rapid reduction of **high IOP**, such as in acute angle-closure glaucoma. *Clonidine* - **Clonidine** is an alpha-2 adrenergic agonist that lowers IOP by reducing aqueous humor production and possibly increasing uveoscleral outflow. - While not a primary glaucoma medication, it has been shown to have an **IOP-lowering effect**. *Acetazolamide* - **Acetazolamide** is a carbonic anhydrase inhibitor that significantly reduces IOP by decreasing the production of aqueous humor. - It is a cornerstone medication for managing **glaucoma** and other conditions requiring IOP reduction.

Q: Which agent stimulates both beta-1 and beta-2 receptors?

Epinephrine. ***Epinephrine*** - **Epinephrine** is a potent agonist at both **beta-1 (β1)** and **beta-2 (β2)** adrenergic receptors, leading to widespread sympathetic nervous system effects. - Its β1 stimulation increases **heart rate** and **contractility**, while β2 stimulation causes **bronchodilation** and vasodilation in certain vascular beds. *Dopamine* - **Dopamine** acts on different receptors depending on the dose: at low doses, it primarily activates **D1 receptors** (renal vasodilation), at intermediate doses, it activates **β1 receptors** (cardiac stimulation), and at high doses, it activates **α1 receptors** (vasoconstriction). - It does not significantly stimulate **beta-2 receptors** at therapeutic concentrations, distinguishing it from epinephrine. *Dobutamine* - **Dobutamine** is a synthetic catecholamine that acts primarily as a **β1-selective agonist**, significantly increasing **myocardial contractility** and heart rate. - While it has some weak β2 agonist activity, its predominant effect is on **β1 receptors**, making it less effective for widespread β2 stimulation compared to epinephrine. *Albuterol* - **Albuterol** is a **short-acting β2-adrenergic agonist** primarily used in the treatment of **asthma** to induce **bronchodilation**. - It has a high selectivity for **β2 receptors** in the lungs and has minimal effects on **β1 receptors** at therapeutic doses.

Q: How does botulinum toxin affect synaptic transmission?

Prevents ACh release. ***Prevents ACh release*** - Botulinum toxin acts by **cleaving SNARE proteins** (SNAP-25, synaptobrevin, syntaxin) which are essential for the fusion of acetylcholine (ACh) vesicles with the presynaptic membrane [2]. - By preventing vesicle fusion, it effectively **blocks the release of ACh** into the synaptic cleft, leading to muscle paralysis [1, 2]. *Inhibits Ca2+ release* - While **calcium influx** is crucial for neurotransmitter release, botulinum toxin's primary mechanism is not direct inhibition of calcium release from the sarcoplasmic reticulum or entry into the presynaptic terminal. - Its action is further downstream, targeting the machinery involved in **vesicle fusion** rather than the initial calcium signal. *Increases K+ influx* - An increase in **potassium (K+) influx** would typically cause hyperpolarization or counteract depolarization, which is not the direct action of botulinum toxin. - Botulinum toxin specifically targets the **release mechanism of neurotransmitters**, not the ion channels responsible for maintaining resting membrane potential or repolarization. *Blocks Na+ channels* - Blocking **sodium (Na+) channels** would prevent depolarization and action potential generation, similar to the mechanism of local anesthetics. - Botulinum toxin does not directly interfere with sodium channel function; its effect is focused on the **vesicular release process of acetylcholine**.

Q: Which drug is commonly used for pupil dilation during an eye exam?

Tropicamide. ***Tropicamide*** - **Tropicamide** is an **anticholinergic** agent that blocks **muscarinic receptors** in the iris **sphincter muscle**, causing **mydriasis** (pupil dilation) and also **cycloplegia** (paralysis of the ciliary muscle). - It has a rapid onset and relatively short duration of action, making it ideal for routine eye examinations. *Latanoprost* - **Latanoprost** is a **prostaglandin analog** primarily used to reduce intraocular pressure in **glaucoma**. - It increases **uveoscleral outflow** of aqueous humor and does not cause pupil dilation. *Timolol* - **Timolol** is a **beta-blocker** used to lower intraocular pressure in **glaucoma** by decreasing the production of aqueous humor. - It does not cause pupil dilation and is often used as a first-line treatment for open-angle glaucoma. *Prednisolone* - **Prednisolone** is a **corticosteroid** used to treat ocular inflammation. - It does not cause pupil dilation and, if used long-term, can actually lead to side effects such as increased intraocular pressure and cataract formation.

Q: Which drug is the specific reversal agent for vecuronium?

Sugammadex. ***Sugammadex*** - **Sugammadex** is a modified gamma-cyclodextrin that forms a tight, water-soluble complex with **rocuronium** and **vecuronium** in plasma, thereby reducing the concentration of free drug available to bind to the **nicotinic acetylcholine receptors**. - This encapsulation effectively reverses the **neuromuscular blockade** induced by these steroidal non-depolarizing muscle relaxants. *Neostigmine* - **Neostigmine** is an **acetylcholinesterase inhibitor** that increases the amount of acetylcholine at the neuromuscular junction, indirectly reversing the effects of non-depolarizing muscle relaxants. - While it can reverse some non-depolarizing agents, it is less effective and carries more **cholinergic side effects** compared to sugammadex for vecuronium reversal. *Edrophonium* - **Edrophonium** is another **acetylcholinesterase inhibitor**, but with a very short duration of action, primarily used for diagnosing myasthenia gravis, not for routine reversal of neuromuscular blockade. - Its rapid onset and brief action make it unsuitable for reversing long-acting neuromuscular blockers like vecuronium due to the risk of **recurarization**. *Atropine* - **Atropine** is an **anticholinergic drug** often given with acetylcholinesterase inhibitors like neostigmine to counteract their muscarinic side effects (e.g., bradycardia, increased secretions). - It does not directly reverse the **neuromuscular blockade** caused by vecuronium but merely manages the side effects of other reversal agents.

Q: A patient is given epinephrine to treat anaphylaxis. Which second messenger system is primarily activated by epinephrine in this situation?

cAMP. ***cAMP*** - Epinephrine primarily acts on **β-adrenergic receptors**, which are G-protein coupled receptors. - Activation of β-adrenergic receptors leads to the stimulation of **adenylyl cyclase**, which converts ATP to **cyclic AMP (cAMP)**, initiating a cascade of intracellular events. *cGMP* - **cGMP** is primarily associated with the activation of **guanylyl cyclases**, which are often stimulated by nitric oxide or natriuretic peptides. - It plays a significant role in **vascular smooth muscle relaxation** and visual transduction, not the primary anaphylactic response to epinephrine. *IP3/DAG* - The **inositol triphosphate (IP3)** and **diacylglycerol (DAG)** pathway is activated by Gq-protein coupled receptors, leading to the mobilization of intracellular calcium and activation of protein kinase C. - While epinephrine can activate **α1-adrenergic receptors** which use this pathway, the predominant life-saving effects in anaphylaxis (bronchodilation, vasoconstriction, cardiac stimulation) are mediated by β-receptors via cAMP. *Calcium ions* - Although **calcium ions** act as a universal second messenger, their increase in the context of epinephrine's primary action in anaphylaxis is often a consequence of other second messenger pathways, such as **IP3/DAG** or direct effects on voltage-gated channels. - **cAMP** is the direct and primary second messenger system activated by the major therapeutic targets of epinephrine during anaphylaxis.

Q: Which drug is used to reverse the effects of non-depolarizing muscle relaxants?

Neostigmine. ***Neostigmine*** - Neostigmine is an **acetylcholinesterase inhibitor** that increases the amount of acetylcholine available at the neuromuscular junction. - This increase in acetylcholine outcompetes the non-depolarizing muscle relaxants, thereby reversing their paralytic effects. *Atropine* - Atropine is an **anticholinergic drug** primarily used to counteract the muscarinic side effects of neostigmine, such as bradycardia and increased secretions. - It does not directly reverse the effects of muscle relaxants but is often co-administered with neostigmine to mitigate its parasympathetic effects. *Glycopyrrolate* - Glycopyrrolate is also an **anticholinergic agent** similar to atropine, used to prevent the muscarinic side effects of acetylcholinesterase inhibitors. - It is preferred over atropine in some cases due to its quaternary ammonium structure, which limits its ability to cross the blood-brain barrier, reducing central nervous system side effects. *Scopolamine* - Scopolamine is an **antimuscarinic agent** primarily used for preventing motion sickness and postoperative nausea and vomiting. - While it has anticholinergic properties, it is not used to reverse non-depolarizing muscle relaxants or to counteract the side effects of neostigmine in this context.

Q: A 65-year-old male with benign prostatic hyperplasia (BPH) is prescribed a drug that relaxes smooth muscle in the bladder neck and prostate. Which alpha-1 blocker is most likely to be prescribed?

Tamsulosin. ***Tamsulosin*** - **Tamsulosin** is a **selective alpha-1A blocker** that specifically targets alpha-1A receptors in the prostate and bladder neck, leading to smooth muscle relaxation and improved urine flow. - Its **uroSelectivity** minimizes cardiovascular side effects (orthostatic hypotension, dizziness), making it the **most commonly prescribed** alpha-1 blocker for **BPH**. - Preferred for patients who need symptomatic relief without significant blood pressure lowering effects. *Alfuzosin* - **Alfuzosin** is a **non-selective alpha-1 blocker** that acts on alpha-1A, 1B, and 1D receptors. - While effective for **BPH**, it has more cardiovascular effects than tamsulosin, including potential for orthostatic hypotension. - Often requires dose titration and may not be suitable for all patients. *Terazosin* - **Terazosin** is a **non-selective alpha-1 blocker** used for both **BPH** and hypertension. - Has significant blood pressure-lowering effects and is associated with **first-dose hypotension**. - Requires gradual dose titration starting from low doses, making it less convenient than tamsulosin. *Doxazosin* - **Doxazosin** is a **non-selective alpha-1 blocker** that relaxes smooth muscle in the prostate and also significantly affects systemic blood pressure. - While effective for **BPH**, its non-selectivity leads to orthostatic hypotension and dizziness, especially with the first dose (**first-dose phenomenon**). - Less preferred when BP control is not needed.

Q: A patient is prescribed a topical prostaglandin analog for glaucoma. Which drug increases the outflow of aqueous humor and may cause iris pigmentation as a side effect?

Latanoprost. ***Latanoprost*** - **Latanoprost** is a **prostaglandin F2α analog** that increases the outflow of aqueous humor through the **uveoscleral pathway**. - A common and unique side effect associated with latanoprost and other prostaglandin analogs is **increased iris pigmentation** (darkening of the iris) and eyelid skin, as well as increased eyelash growth. *Timolol* - **Timolol** is a **non-selective beta-blocker** that reduces aqueous humor production, thereby lowering intraocular pressure. - It does not significantly affect aqueous humor outflow and is not associated with iris pigmentation changes. *Brimonidine* - **Brimonidine** is an **alpha-2 adrenergic agonist** that reduces aqueous humor production and also slightly increases uveoscleral outflow. - While effective in lowering intraocular pressure, it is not primarily associated with iris pigmentation changes. *Acetazolamide* - **Acetazolamide** is a **carbonic anhydrase inhibitor** that decreases the production of aqueous humor. - It is often used systemically or topically (dorzolamide, brinzolamide) but does not impact aqueous humor outflow or cause iris pigmentation.

Question 1

Which of the following is a contraindication to the use of Beta Blockers:

Accepted Answer

Severe asthma with bronchospasm

Answer

Thyroid storm

Answer

Glaucoma

Answer

AV nodal reentrant tachycardia (AVNRT)

Question 2

All are drugs which lower IOP except:

Accepted Answer

Dexamethasone

Answer

Mannitol

Answer

Clonidine

Answer

Acetazolamide

Question 3

Which agent stimulates both beta-1 and beta-2 receptors?

Accepted Answer

Epinephrine

Answer

Dopamine

Answer

Dobutamine

Answer

Albuterol

Question 4

How does botulinum toxin affect synaptic transmission?

Accepted Answer

Prevents ACh release

Answer

Inhibits Ca2+ release

Answer

Increases K+ influx

Answer

Blocks Na+ channels

Question 5

Which drug is commonly used for pupil dilation during an eye exam?

Accepted Answer

Tropicamide

Answer

Latanoprost

Answer

Timolol

Answer

Prednisolone

Question 6

Which drug is the specific reversal agent for vecuronium?

Accepted Answer

Sugammadex

Answer

Neostigmine

Answer

Edrophonium

Answer

Atropine

Question 7

A patient is given epinephrine to treat anaphylaxis. Which second messenger system is primarily activated by epinephrine in this situation?

Accepted Answer

cAMP

Answer

cGMP

Answer

IP3/DAG

Answer

Calcium ions

Question 8

Which drug is used to reverse the effects of non-depolarizing muscle relaxants?

Accepted Answer

Neostigmine

Answer

Atropine

Answer

Glycopyrrolate

Answer

Scopolamine

Question 9

A 65-year-old male with benign prostatic hyperplasia (BPH) is prescribed a drug that relaxes smooth muscle in the bladder neck and prostate. Which alpha-1 blocker is most likely to be prescribed?

Accepted Answer

Tamsulosin

Answer

Alfuzosin

Answer

Terazosin

Answer

Doxazosin

Question 10

A patient is prescribed a topical prostaglandin analog for glaucoma. Which drug increases the outflow of aqueous humor and may cause iris pigmentation as a side effect?

Accepted Answer

Latanoprost

Answer

Timolol

Answer

Brimonidine

Answer

Acetazolamide

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?